TEMENOS
15.1.2020 08:02:08 CET | Business Wire | Press release
- Larger banks can now renovate their core banking applications component by component without compromising their end goal of a full system transformation to a cloud-agnostic, cloud-native architecture. Temenos Transact microservices architecture enables continuous change with tangible business benefits at every stage.
- Temenos Transact microservices - such as accounts and deposits, and retail lending - can be integrated through APIs in any sequence with any legacy infrastructure, quickly and safely, helping banks to unlock the power of digital transformation.
- Temenos offers banks a real choice of transformation strategies, from continuous renovation where larger banks replace components of their architecture one at a time to ‘build and renovate’ - where they can build a new digital stack while continuously migrating products and customer bases from their legacy systems.
- Temenos Transact microservices can deliver enterprise-wide capabilities such as pricing on top of legacy infrastructures as a first step toward creating value for the bank. For a complete digital banking transformation, Transact works in conjunction with microservices-based Temenos Infinity.
- Temenos Transact is built on cloud-native, cloud-agnostic technology that enables banks to significantly reduce their total cost of ownership through elastic cloud scalability, distributed database technology and multi-cloud resilience, all underpinned by the benefits of vendor and platform independence
Temenos (SIX: TEMN), the banking software company, announced that it has reached a major milestone in the delivery of its microservices-based architecture for cloud-native, cloud-agnostic Temenos Transact. This unlocks the potential for Tier 1 banks to strategically transform their core banking systems at scale.
Large banks are burdened by their legacy infrastructures. The cost and associated risk of replacing these complex systems, which have been customized over decades, is high. However, these outdated systems are making banks suffer high operational costs, high risk of outages, and a lack of agility that prevents them from bringing innovative, personalized products to market. The urgency to digitally transform has never been greater.
Temenos is now accelerating the roll-out of its microservices to help larger banks continuously transform their core banking applications. Unlike traditional monolithic core banking systems, Temenos Transact has independently deployable components that support continuous renovation based on the bank’s business needs. For the first time, there is now an alternative for banks to safely update critical elements of their core banking systems one component at a time with proven cloud-native, cloud-agnostic software and see tangible benefits along the way. These microservices can be deployed independently, enterprise wide and banks can retain existing systems where they are fit for purpose. Combined with microservices-based Temenos Infinity, banks have an agile, services based architecture for both core banking and digital customer journeys. This offers an alternative to the already successful build and migrate implementation approach, where banks can build a new digital stack while continuously migrating products and customer bases from their legacy systems.
Banks can pursue a long-term strategic roadmap while continuously renovating product lines, such as deposits and accounts, and core systems such as funds authorization and position keeping, based on their commercial and operational priorities. This strategy enables banks to flex the sequence of renovation as priorities change over time.
Temenos’ microservices strategy offers existing Temenos Transact clients the benefit of granular upgrades, allowing them to react to market opportunities faster while cutting the total cost of ownership of their existing core banking platform. Leveraging Temenos Continuous Deployment , which extends the Temenos DevOps operations into banks’ own environments, Temenos clients can accelerate the speed of software delivery and rapidly bring competitive innovations to market.
For smaller banks, the recommended approach is to select Temenos Transact as a SaaS offering to speed deployment and simplify IT operations.
Building on its extensive set of standalone services - such as Payments, Financial Crime Mitigation, Enterprise Data Management and Analytics - Temenos now offers new standalone banking microservices including:
- Accounts and Deposits: this service manages all the activities in the life of current, checking and deposit accounts in real time. Feature-rich, it supports any currency and offers a great variety of interest calculation methods and configurable business rules and events. Fully automated, the service integrates seamlessly through APIs with distribution services and other core systems such as payments, pricing, accounting. Deployed as a microservice, it leverages the cloud’s elastic scalability to manage millions of accounts with the lowest TCO.
- Retail Lending: this service manages a wide range of lending products, from simple unsecured consumer loans in any currency to complex facilities including multiple loans and associated collateral requirements. Designed for real-time processing and highly configurable, Retail Lending is rich and flexible enough to replace a number of legacy systems within the bank. Through APIs, it will integrate with the rest of the IT ecosystem, in the cloud or on premise.
- Enterprise product : a standalone product catalogue that enables banks to design and take to market products on a single system, reducing cost and boosting profitability of products. The service enables financial institutions to centralize all product definitions in a common repository, giving them greater overview and control across multiple business lines often working in silos. It helps banks launch new products and commercial offers much faster.
- Enterprise pricing: a central pricing engine that supports greater personalization of products services driven by AI, and improves time to market for all product types, including bundled products, relationship-based pricing and third-party products. Banks can get greater control over the fees they apply, often within disconnected applications. This increases profitability for the banks. With relationship pricing, they are able to define granular rules based on the client’s characteristics and the context of a transaction, and thus offer a personalized banking experience to each customer.
Temenos Transact microservices are functionally rich, enabling fast deployment without the need to build additional capabilities on top. Temenos has created reusable country Model Banks, which include regulatory compliance and best business practice solutions, for more than 150 countries. This helps banks go live faster and acts as a foundation for future innovation.
Max Chuard, Chief Executive Officer, Temenos, said : "To date, larger banks have been shying away from digital transformation projects. As the #1 banking software company, we are taking the lead in bringing about industry change. We are delivering the Temenos Transact microservices architecture, which will revolutionize banking. This microservices-based cloud architecture enables large banks to finally unlock their potential by transforming their core banking applications rapidly and at scale. Larger banks can renovate their core banking applications without compromising their end goal of a full digital transformation to a cloud-agnostic, cloud-native architecture, one component at a time. This is an alternative to the already successful build and migrate approach where, banks can build a new digital stack while continuously migrating products and customer bases from their legacy systems.
"We have a proven track record of helping banks to digitally transformation. Our high-performing clients using Temenos software have achieved industry-leading cost-income ratios of 25.2% and returns on equity of 25.0%, 2X better than the industry average. Only Temenos has the advanced technology and depth of banking expertise and to deliver this."
Temenos Transact microservices leverage cloud-native, cloud-agnostic technology to improve efficiency by allowing banks to scale quickly and elastically while benefiting from multi-cloud resilience. Temenos gives banks freedom of choice to deploy software on premise, in any public cloud, or as a Temenos SaaS.
- Ends –
About Temenos
Temenos AG (SIX: TEMN), headquartered in Geneva, is the world’s leader in banking software, partnering with banks and other financial institutions to transform their businesses and stay ahead of a changing marketplace. Over 3,000 banks across the globe, including 41 of the top 50 banks, rely on Temenos to process both the daily transactions and client interactions of more than 500 million banking customers. Temenos offers cloud-native, cloud-agnostic front office and core banking, payments, fund management and wealth management software products enabling banks to deliver consistent, frictionless customer journeys and gain operational excellence.
Temenos software is proven to enable its top-performing clients to achieve industry-leading cost-income ratios of 25.2% and returns on equity of 25.0%, 2X better than the industry average. These clients also invest over 53% of their IT budget on growth and innovation versus maintenance, which is 2.5X the industry average, proving the banks’ IT investment is adding tangible value to their business.
For more information, please visit www.temenos.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20200114005069/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press release
REACH study met its first primary endpoint, showing that Broncho‑Vaxom® (OM‑85) was associated with a 28-38% reduction in respiratory tract infection rates at 12 months and 29-41% reduction at 24 months, comparing post-treatment versus pre-treatment initiation.1 The reduction was observed regardless of the frequency of respiratory tract infections in the previous year (1-3, >3) and across age subgroups (1-5, 6-11, 12-17, 18-64, >64 years).1 By reflecting everyday clinical practice and capturing episodes that necessitated a visit to the doctor, these extensive data offer critical new evidence of the therapy’s long-term relevance for patients suffering from recurrent respiratory tract infections. Evaluating a vast cohort of more than 15,790 paediatric, adolescent, adult and elderly patients in China, Italy, and Belgium, REACH represents the largest and only multi-country real-world evidence study to date for Broncho-Vaxom®.1,2 The study cohort includes patients with different co-morbidit
Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press release
In myelofibrosis (MF), INCA033989 delivered rapid and durable clinical benefits including meaningful spleen volume reductions, symptom improvement and anemia responses, both as a monotherapy and in combination with ruxolitinibIn essential thrombocythemia (ET), 87% of patients achieved a hematologic response, including 70% complete responses; responses were rapid (median ~2 weeks to a durable complete hematologic response) and durable (median response duration of 23 weeks)Across MF and ET, INCA033989 consistently reduced mutant CALR (mutCALR) variant allele frequency (VAF) in most evaluable patients, with reductions correlating with clinical responses and supporting its potential for disease modificationFirst-in-class mutCALR-targeted antibody shows potential to modify disease biology in both MF and ETINCA033989 demonstrated a favorable and manageable safety profile with no dose-limiting toxicities, with most patients with MF and ET continuing treatment Incyte (Nasdaq:INCY) today announ
Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press release
- frontMIND study evaluating tafasitamab (Monjuvi®/Minjuvi®) in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL) selected for the prestigious Plenary Abstracts Session at EHA 2026 - Results showed tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) significantly prolonged progression-free survival (PFS), reducing risk of disease progression or death by 25% - Positive trends toward PFS benefit with Tafa-Len-R-CHOP were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypes - The frontMIND data support global regulatory applications for tafasitamab and lenalidomide in addition to R-CHOP for previously untreated DLBCL and HGBL Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified c
Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202612.6.2026 23:31:00 CEST | Press release
Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til
IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 18:36:00 CEST | Press release
Venneman brings more than 30 years of digital transformation, AI, and enterprise technology experience as IQM prepares for its planned Nasdaq listing IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
